Please click on the relevant link for the information you require
All content is applicable to NHS South West London and SWL Providers (including Acute Trusts, Mental Health Trust and Community Services providers).
Hyperhidrosis (Update October 2026)
The treatment guideline for hyperhidrosis has been updated to include NICE TA1175: Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis.
Antimicrobial guidelines (Updated Sept 2026)
The section on Helicobacter Pylori (H.pylori) within the antimicrobial guidelines has been updated.
Acute Migraine guideline (Updated Aug 2026)
The acute migraine (in adults) guideline has been updated.
Denosumab (Osvyrti brand only): Shared care for the treatment of osteoporosis in post menopausal women (New September 2026)
New shared care – Denosumab (Osvyrti brand only) for the treatment of osteoporosis post menopausal women within rheumatology service.
Erectile Dysfunction guidelines (Updated August 2026)
Updated Erectile Dysfunction guidelines (adults)
Diabetes blood glucose and ketone meters, testing strips and lancets position statement (Updated June 2026)
Updated position statement for diabetes blood glucose and ketones meters, testing strips and lancets.
Lipid guidelines (Updated May 2026)
The updated lipid guidelines is intended for primary care clinicians working within NHS South West London to support the assessment, initiation and optimisation of lipid lowering therapy in adults for the primary and secondary prevention of cardiovascular disease.
SGLT2 (Sodium glucose co-transporter-2) inhibitors in management of heart failure (Updated April 2026)
The information sheet for SGLT-2 inhibitors in the management of heart failure in adults has been updated.
Guanfacine (adults) shared care (New March 2026)
New shared care- Guanfacine for patients in adults services
Bezafibrate shared care (New)
The bezafibrate shared care guidance is for use in patients within hepatology.
Epilepsy (adults) (New)
The Epilepsy (adults) guidance is intended for use by clinicians when using anti-seizure medication (ASM), also called antiepileptic drugs (AEDs).
Midodrine prescribing guidance (New Dec 2025)
The Midodrine prescribing guidance is aimed at primary and secondary care clinicians involved in the management of patients with;
- Inappropriate sinus tachycardia (IST),
- Postural orthostatic tachycardia syndrome (POTS)
- Severe orthostatic hypotension due to autonomic dysfunction.
